Metabolic inhibitors affect the conductance of low voltage-activated calcium channels in brain capillary endothelial cells.
Delpiano
M A
MA
Max-Planck-Institut für Molekulare Physiology, Dortmund, Germany.
D019297:2,4-Dinitrophenol / Q000494:pharmacology*; D000200:Action Potentials / Q000187:drug effects; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D001921:Brain / Q000098:blood supply; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000187:drug effects* / Q000378:metabolism; D002196:Capillaries / Q000187:drug effects / Q000378:metabolism; D015687:Cell Hypoxia / Q000187:drug effects; D002478:Cells, Cultured; D018999:Charybdotoxin / Q000494:pharmacology; D004095:Dihydropyridines / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects; D015640:Ion Channel Gating / Q000187:drug effects; D017136:Ion Transport / Q000187:drug effects; D009532:Nickel / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D011188:Potassium / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D012966:Sodium Cyanide / Q000494:pharmacology*; D013779:Tetrodotoxin / Q000494:pharmacology
D000963:Antimetabolites; D015220:Calcium Channels; D004095:Dihydropyridines; D015221:Potassium Channels; D018999:Charybdotoxin; D013779:Tetrodotoxin; D000584:Amiloride; C038806:1,4-dihydropyridine; D009532:Nickel; D012966:Sodium Cyanide; D019297:2,4-Dinitrophenol; D011188:Potassium; D002118:Calcium